Hanmi Science Co

Hanmi Science Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Hanmi Science Co (008930.KS) as of Oct 11, 2026 is 49.39. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 38.59 — a change of 28.00% (higher).

EV/EBIT

49.39

YoY

28.00%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Hanmi Science Co is 2025 49.39 . EV/EBIT (Enterprise Value to EBIT) of Hanmi Science Co was 2024 38.59 . It decreases by 28.00% higher compared to the previous year.

The Hanmi Science Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2018
238.97 KRW
Jan 1, 2019
158.63 KRW
Jan 1, 2020
88.96 KRW
Jan 1, 2021
55.30 KRW
Jan 1, 2022
36.66 KRW
Jan 1, 2023
49.35 KRW
Jan 1, 2024
38.59 KRW
Jan 1, 2025
49.39 KRW
The Hanmi Science Co EV/EBIT history
YEAREV/EBITYoY
49.39+28.00%
38.59-21.81%
49.35+34.62%
36.66-33.71%
55.30-37.84%
88.96-43.92%
158.63-33.62%
238.97+21.95%
195.97+4.95%
186.73+876.08%
19.13-93.68%
302.75+232.29%
91.11+7.24%
84.96+40.13%
60.63+82.02%
33.31+353.20%
7.35+38.68%
5.30-32.14%
7.81+2.49%
7.62—
Access this data via the Eulerpool API

Hanmi Science Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Hanmi Science Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Hanmi Science Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Hanmi Science Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Hanmi Science Co grows earnings faster than its peers.

Hanmi Science Co Stock analysis

What does Hanmi Science Co do? Hanmi Science Co Ltd is a South Korean company specializing in the manufacturing of pharmaceutical products, biologics, and medical devices. The company was founded in 1973 as a chemical company and obtained the license for drug manufacturing in 1990, expanding its product range to include pharmaceuticals. Today, the company's business model includes three main areas: research and development, manufacturing and sales of drugs, and sales of medical devices. Hanmi aims to develop and produce innovative and high-quality products to improve people's health worldwide. In the field of research and development, Hanmi Science is a leading company. It specializes in the research and development of novel drugs and biologics. The company has an impressive track record in the development and marketing of innovative drugs for the treatment of diabetes, cancer, and rare diseases. This includes a range of biosimilars produced using biotechnological methods that are more affordable compared to original medical substances. Hanmi also has a state-of-the-art production infrastructure that meets the highest quality standards and ensures reliable supply. In the field of drug manufacturing, the company produces generics and biosimilars that are sold in more than 50 countries worldwide. Hanmi also specializes in the production of chemotherapeutics and parenteral drugs that have proven efficacy and safety. The medical device sales division focuses on marketing high-quality medical devices, including diagnostic and monitoring devices used in the medical field. Hanmi also distributes a range of medical consumables, including transfusion sets, syringes, infusion sets, and catheters. Hanmi Science Co Ltd offers a wide range of products that can be categorized into various categories. Among the pharmaceutical products are antidiabetic drugs, anticancer agents, antidepressants, antibiotics, antiviral medications, and products for the treatment of rare diseases. The portfolio also includes biosimilars of botulinum toxin, insulin, and humiderm among the biologics. Overall, Hanmi Science Co Ltd holds a strong position in the South Korean market and has also established a good reputation internationally. With its focus on research and development and the production of high-quality drugs and medical devices, the company has a promising future. Hanmi Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hanmi Science Co stock

EV/EBIT (Enterprise Value to EBIT) of Hanmi Science Co is 49.39 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Hanmi Science Co changed from 38.59 to 49.39, representing a 28.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Hanmi Science Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Hanmi Science Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Hanmi Science Co

All Key Metrics — Hanmi Science Co